Tenosynovitis is an inflammatory process affecting the sheath of a tendon. Both extensor and flexor tendons can become affected, and the wrists or hands are commonly involved. Tenosynovitis can often result in pain, swelling, and contracture of the affected tendon/extremity. When tenosynovitis reduces the ability for the tendon sheath to normally glide within its tendon sheath, it may result in a condition called stenosing tenosynovitis. Identification and treatment of tenosynovitis are essential in preventing further progression of the disease, which can lead to limitations to motion, chronic contractures, and deformity.
The causes of tenosynovitis are broad and commonly include infectious, autoimmune, systemic disorders, overuse, and chronic degeneration. Many cases of tenosynovitis are idiopathic. Infectious tenosynovitis can result from direct inoculation, spread from adjacent tissues, and via hematogenous spread and offending organisms often include S. aureus, streptococci, and polymicrobial infections. Autoimmune etiologies also remain broad; however, psoriatic arthritis and rheumatoid arthritis are common offenders. Systemic etiologies include common disorders of diabetes, gout, and calcium pyrophosphate deposition disease, and thyroid disease amongst less common others. Overuse and degenerative changes are often a linked etiology stemming from excessive or improper use of a tendon resulting in damage over short or long periods.
Tenosynovitis remains a common condition, with its incidence, prevalence, and distribution remaining variable depending on the etiology. For the general population taken as a whole, the incidence is between 1.7% to 2.6% for the stenosing form of tenosynovitis. This number is much higher for persons with diabetes, ranging from 10 to 20%. Of those who develop infections of the hand, only 2.5% to 9.4% of patients will go on to develop infectious tenosynovitis. Individuals with rheumatoid arthritis are significantly at risk of tenosynovitis, with 55% of patients reporting symptoms averaging 3.1 tendons.
Regardless of the etiology, the mechanism of tenosynovitis remains similar to the hallmark findings of inflammation within the tendon sheath. Purulence, autoimmune complexes, crystalline deposit, overuse, and other etiologies as above often affect the tendon synovium (the fluid around the tendon) or the tendon itself, resulting in inflammation and thickening. The natural gliding properties of the tendon sheath complex become compromised as a result. While most tendons are at least partially contained by a tendon sheath and are therefore prone to tenosynovitis, some tendons are not contained in a tendon sheath, such as the Achilles tendon. Of important note, infectious tenosynovitis progresses over a series of surgically significant stages. The first stage demonstrates exudative distension of the tendon sheath apparatus, the second stage involves purulent filling, and the third stage 3 results in necrosis and destruction of the sheath, tendon, and adjacent structures.
A detailed history focusing on possible etiologies is essential, as the cause actively directs treatment of tenosynovitis. A history of injury, fever, ulceration, or purulence with acute digit contracture or pain upon flexion/extension would suggest an infectious etiology, whereas a history of longstanding arthritis or autoimmune disorder with slowly progressing symptoms would suggest a chronic systemic process.
Physical exam findings vary based on cause and extent; however, in general, demonstrate swelling, pain, erythema, and difficulty moving the affected joint. For infectious flexor tenosynovitis, the “Kanavel signs” are important to recognize:
These signs are 91 to 97% sensitive for pyogenic flexor tenosynovitis, however with a reduced specificity of 51 to 69%. Other etiologies of tenosynovitis present with a variety of physical manifestations. In rheumatoid arthritis, rheumatoid nodules or hand deformities may be helpful, while crystalline causes can sometimes be elucidated based on the finding of tophi or evidence of deposition on the exam. Other times, the physical exam may be non-elucidative such as in chronic overuse injury. Progression of tenosynovitis into can result in visible contracture deformities and inability to relax the tendon.
Stenosing tenosynovitis, a phenomenon resulting from enlargement of the flexor tendon relative to the flexor retinaculum pulley (A1 pulley), results in “catching” or “locking” of the joint. In the fingers, this is known as trigger finger, resulting in flexion contractures at the PIP joints. Stenosing tenosynovitis of the extensor pollicis brevis (EBL) and abductor pollicis longus (APL) results in PIP contractures of the thumb, often with a positive Finklestein test, (adduction of the hand and wrist together) and is known as de Quervain tenosynovitis.
Laboratory evaluation can help evaluate and differentiate between the causes of tenosynovitis. However, it is not always necessary. When suspecting infectious causes of tenosynovitis, findings of elevated WBC, bacteremia, and culture may be helpful. Autoinflammatory diseases may demonstrate specific markers to assist in the diagnosis. Microscopic evaluation can further help in distinguishing crystalline pathology from infection or inflammation when suspected.
Imaging evaluation is helpful, yet not always necessary when diagnosing tenosynovitis. Plain film radiographs often show calcifications of the synovial membrane or at times periosteal reaction, suggesting inflammation, however, may be negative altogether. Computed tomography can be useful for detecting bony abnormalities such as bony erosions or structural anomalies, but its soft tissue sensitivity for synovitis and tenosynovitis remains low.
Ultrasound can often add diagnostic benefits, particularly in the hands where it can show echotexture changes in 15% of tendons and blurring of the tendon margins in 62%. Additionally, tendon thickening could be visible in 44% of fingers with an additional 6% demonstrating sheath cysts and 4% with further abnormalities of the metacarpophalangeal joints.
When ultrasound is limited or additional fine detail evaluation is required, further evaluation with MRI is an option. Contrast should be a consideration in cases concerning for infectious etiologies for abscess visualization. MRI features of tenosynovitis can vary based on etiology, however, commonly demonstrate peritendinous edema and increased thickening of the EBL and APL tendons in cases of de Quervain tenosynovitis. In rheumatoid arthritis, bone marrow signal may increase even before symptoms of tenosynovitis. Fluid collections demonstrating enhancement are suspicious for abscess formation.
Infectious tenosynovitis treatment can vary based on the offending agent when known, however, when empiric treatment is necessary, broad-spectrum antibiotics such as Vancomycin at 15 to 20mg/kg/dose every 8 to 12 hours with a third-generation cephalosporin at 1 to 2g IV every 24 hours are considered and may improve outcomes. Duration depends on clinical findings and the presence or absence of bacteremia, as well as the source of the infection. Sheath irrigation is a possibility in patients with stage 1 infection, with catheter-directed therapy resulting in improved outcomes compared to open irrigation. Patients with stage 2 or 3 infections will likely require debridement.
Noninfectious causes of tenosynovitis vary in their treatment based on etiology; however, many are treated conservatively with non-steroidal anti-inflammatory drugs such as naproxen. Additional first-line treatment may consist of activity modification, splinting, and glucocorticoid injections. Disease-modifying antirheumatic drugs (DMARDs) such as glucocorticoids may be additionally helpful in patients in patients who fail NSAID trial. Surgical intervention may become necessary after 3 to 6 months of progression despite conservative therapy. Surgical intervention may involve the decompression of affected tendons as well as debridement of inflammatory tissues.
A variety of diseases may mimic or contribute to tenosynovitis; common examples appear below.
In cases of infectious tenosynovitis, the best outcomes are related to early empiric antimicrobial therapy and early irrigation or debridement when necessary. Poor prognostic factors of infectious tenosynovitis include infection by Streptococcus pyogenes or multiple agents, delayed antibiotics and surgical intervention, purulence of the tissue, diabetes mellitus, renal failure, and peripheral vascular disease. Stage 3 disease involving necrosis and destruction offers the worst outcomes, with a 59% amputation rate.
The prognosis for non-infectious tenosynovitis is highly variable dependent on the etiology. However, those suffering from the stenosing form have a relatively good prognosis, with 93% finding improvement in finger-based symptoms within 6 to 10 weeks of wearing a thermoplastic splint, 54% with complete resolution. Those who fail more conservative therapy and require glucocorticoids can expect persistent relief greater than one year in about 50% of patients. Surgical patients also experience a good prognosis with recurrence of symptoms in only 4.6% of patients. Diabetic patients are a special group that does not respond as well to either steroid or surgical therapy.
The rate of complications for infectious/pyogenic tenosynovitis is high at 38% and includes long term finger stiffness, boney/tendinous deformation, further infection into the deep spaces of the hand, necrosis of the tendon, adhesions, and eventual need for amputation.
Patients suffering from the non-infectious form of tenosynovitis may progress into the stenosing form of tenosynovitis resulting in chronic contractures and flexion deformities requiring surgery. Treatment of non-infectious tenosynovitis carries additional complications, especially in those requiring surgery, such as infection, injury of the nerve, deformities of the flexor tendon, and scarring of the tissue.
Avoidance of situations that increase the risk of infection to the hands is vital in preventing infectious tenosynovitis. Early detection of infectious signs such as tenderness, pain, contracture, and enlargement of a digit by the patient is important in determining good outcomes. Patients suffering from non-infectious tenosynovitis should identify and avoid activities that worsen symptoms and take preventative care by addressing a systemic disease that may influence tenosynovitis.
Refractory non-infectious tenosynovitis and any form of infectious tenosynovitis may warrant consultation of an orthopedic surgeon for further evaluation and treatment, including surgery. The consultation of an infectious disease specialist may also be beneficial in patients suffering from infectious tenosynovitis where narrowing or broadening of antibiotic coverage and determining the length of treatment is necessary. Rheumatology may be able to further assist in the causes and treatment of the non-infectious etiologies of tenosynovitis. The inclusion of radiology in the assessment of the tenosynovitis can additionally support the interdisciplinary team by providing the imaging findings and their associated interpretations.
In summary, tenosynovitis requires an interprofessional team approach, including physicians, specialists, specialty-trained nurses, and pharmacists, all collaborating across disciplines to achieve optimal patient results. [Level V]
|||Millerioux S,Rousset M,Canavese F, Pyogenic tenosynovitis of the flexor hallucis longus in a healthy 11-year-old boy: a case report and review of the literature. European journal of orthopaedic surgery [PubMed PMID: 23412272]|
|||Adams JE,Habbu R, Tendinopathies of the Hand and Wrist. The Journal of the American Academy of Orthopaedic Surgeons. 2015 Dec; [PubMed PMID: 26510626]|
|||McAuliffe JA, Tendon disorders of the hand and wrist. The Journal of hand surgery. 2010 May; [PubMed PMID: 20438999]|
|||Small LN,Ross JJ, Suppurative tenosynovitis and septic bursitis. Infectious disease clinics of North America. 2005 Dec; [PubMed PMID: 16297744]|
|||Cagliero E,Apruzzese W,Perlmutter GS,Nathan DM, Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. The American journal of medicine. 2002 Apr 15; [PubMed PMID: 11959060]|
|||Strom L, Trigger finger in diabetes. The Journal of the Medical Society of New Jersey. 1977 Nov; [PubMed PMID: 269967]|
|||Giladi AM,Malay S,Chung KC, A systematic review of the management of acute pyogenic flexor tenosynovitis. The Journal of hand surgery, European volume. 2015 Sep; [PubMed PMID: 25670687]|
|||Gray RG,Gottlieb NL, Hand flexor tenosynovitis in rheumatoid arthritis. Prevalence, distribution, and associated rheumatic features. Arthritis and rheumatism. 1977 May; [PubMed PMID: 871301]|
|||Michon J, [Phlegmon of the tendon sheaths]. Annales de chirurgie. 1974 Apr; [PubMed PMID: 4839194]|
|||Hyatt BT,Bagg MR, Flexor Tenosynovitis. The Orthopedic clinics of North America. 2017 Apr; [PubMed PMID: 28336044]|
|||Pang HN,Teoh LC,Yam AK,Lee JY,Puhaindran ME,Tan AB, Factors affecting the prognosis of pyogenic flexor tenosynovitis. The Journal of bone and joint surgery. American volume. 2007 Aug; [PubMed PMID: 17671013]|
|||Kennedy CD,Lauder AS,Pribaz JR,Kennedy SA, Differentiation Between Pyogenic Flexor Tenosynovitis and Other Finger Infections. Hand (New York, N.Y.). 2017 Nov; [PubMed PMID: 28720000]|
|||Blood TD,Morrell NT,Weiss AP, Tenosynovitis of the Hand and Wrist: A Critical Analysis Review. JBJS reviews. 2016 Mar 29; [PubMed PMID: 27500430]|
|||Kostman JR,Rush P,Reginato AJ, Granulomatous tophaceous gout mimicking tuberculous tenosynovitis: report of two cases. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1995 Jul; [PubMed PMID: 7578737]|
|||Østergaard M,Boesen M, Imaging in rheumatoid arthritis: the role of magnetic resonance imaging and computed tomography. La Radiologia medica. 2019 Mar 18; [PubMed PMID: 30880357]|
|||Kim HR,Lee SH, Ultrasonographic assessment of clinically diagnosed trigger fingers. Rheumatology international. 2010 Sep; [PubMed PMID: 19851771]|
|||Müller CT,Uçkay I,Erba P,Lipsky BA,Hoffmeyer P,Beaulieu JY, Septic Tenosynovitis of the Hand: Factors Predicting Need for Subsequent Débridement. Plastic and reconstructive surgery. 2015 Sep; [PubMed PMID: 26313838]|
|||Mamane W,Lippmann S,Israel D,Ramdhian-Wihlm R,Temam M,Mas V,Pierrart J,Masmejean EH, Infectious flexor hand tenosynovitis: State of knowledge. A study of 120 cases. Journal of orthopaedics. 2018 Jun; [PubMed PMID: 29881224]|
|||Wagner ER,Gottschalk MB, Tendinopathies of the Forearm, Wrist, and Hand. Clinics in plastic surgery. 2019 Jul; [PubMed PMID: 31103076]|
|||Colbourn J,Heath N,Manary S,Pacifico D, Effectiveness of splinting for the treatment of trigger finger. Journal of hand therapy : official journal of the American Society of Hand Therapists. 2008 Oct-Dec; [PubMed PMID: 19006759]|
|||Rozental TD,Zurakowski D,Blazar PE, Trigger finger: prognostic indicators of recurrence following corticosteroid injection. The Journal of bone and joint surgery. American volume. 2008 Aug; [PubMed PMID: 18676896]|
|||Hammer HB,Kvien TK,Terslev L, Tenosynovitis in rheumatoid arthritis patients on biologic treatment: involvement and sensitivity to change compared to joint inflammation. Clinical and experimental rheumatology. 2017 Nov-Dec; [PubMed PMID: 28516887]|
|||Fiorini HJ,Tamaoki MJ,Lenza M,Gomes Dos Santos JB,Faloppa F,Belloti JC, Surgery for trigger finger. The Cochrane database of systematic reviews. 2018 Feb 20; [PubMed PMID: 29460276]|
|||Mishra SR,Gaur AK,Choudhary MM,Ramesh J, Percutaneous A1 pulley release by the tip of a 20-g hypodermic needle before open surgical procedure in trigger finger management. Techniques in hand [PubMed PMID: 23689860]|
|||Stahl S,Kanter Y,Karnielli E, Outcome of trigger finger treatment in diabetes. Journal of diabetes and its complications. 1997 Sep-Oct; [PubMed PMID: 9334911]|
|||Ryzewicz M,Wolf JM, Trigger digits: principles, management, and complications. The Journal of hand surgery. 2006 Jan; [PubMed PMID: 16443118]|